Navigation Links
Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
Date:5/13/2009

NATICK, Mass., May 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices to Heartbeat International, a non-profit organization dedicated to providing CRM devices and medical care at no charge to needy patients in countries outside the United States. The donation marks the beginning of the Company's agreement to provide Heartbeat International with CRM devices that would otherwise remain unused.

"We are very pleased to be able to donate life-saving and life-enhancing medical devices through Heartbeat International," said Fred Colen, President, Boston Scientific Cardiac Rhythm Management. "We are proud to support the humanitarian efforts of this organization and help advance their mission to serve those in need."

Heartbeat International operates 41 approved distribution centers in 22 countries. Volunteer physicians provide implantation procedures and follow-up care at local hospitals at no charge. Heartbeat International also works closely with regulatory bodies to confirm compliance with applicable laws and has partnered with Rotary International to verify that devices are implanted only in patients with medical need and severely limited economic resources.

"Each year more than one million people die or live a compromised life because they need but cannot afford an implantable device," said Wil Mick, President and Chief Operating Officer of Heartbeat International. "Thanks to donations from companies like Boston Scientific, we can help save or improve the lives of many who otherwise could not afford these advanced therapies."

In addition to donating devices, Boston Scientific will provide device programmers, programmer software and software updates, and implant accessories to Heartbeat International to support device implant and follow-up care.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our philanthropic activities, products and product performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

    CONTACT:  Paul Donovan
              508-650-8541 (office)
              508-667-5165 (mobile)
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696 (office)
              Investor Relations
              Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... Crucial ... trial sites and study participants truly unified. TrialKit, a native mobile app, empowers ... Part 11) research studies entirely on mobile devices. With TrialKit, clinical researchers can ...
(Date:7/18/2017)... ... July 18, 2017 , ... ... States Patent and Trademark Office for its Patent Applications 14/858,857 and 13/669,785 both ... of these patent applications further expand the protection of G-CON’s R&D investments and ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... device testing capabilities to encompass the full series of ISO 80369 standard test ... fittings for medical device and drug delivery systems. With this recent expansion, Whitehouse ...
(Date:7/17/2017)... Linda, Ca (PRWEB) , ... July 17, 2017 ... ... heterogeneous and are characterized by a wide range of overlapping clinical features. The ... of discovery in the field of NDD research and testing. , However, ...
Breaking Biology Technology:
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Biology News(10 mins):